DBV Technologies
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. The company's product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of i… Read more
DBV Technologies (DBVT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.614x
Based on the latest financial reports, DBV Technologies (DBVT) has a cash flow conversion efficiency ratio of -0.614x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-32.44 Million) by net assets ($52.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DBV Technologies - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how DBV Technologies's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DBV Technologies Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DBV Technologies ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Indian Energy Exchange Limited
NSE:IEX
|
-0.007x |
|
Biohaven Pharmaceutical Holding Co Ltd
NYSE:BHVN
|
-2.509x |
|
Paladin Energy Ltd
OTCQX:PALAF
|
-0.003x |
|
Leroy Seafood Group ASA
LSE:0GM2
|
0.061x |
|
Xior Student Housing NV
PINK:XIORF
|
0.014x |
|
Jamf Holding
NASDAQ:JAMF
|
0.083x |
|
Wilhelm Wilhelmsen Holding ASA
LSE:0P0T
|
0.009x |
|
VisEra Technologies Co. Ltd.
TW:6789
|
0.068x |
Annual Cash Flow Conversion Efficiency for DBV Technologies (2011–2024)
The table below shows the annual cash flow conversion efficiency of DBV Technologies from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $27.39 Million | $-104.47 Million | -3.815x | -571.38% |
| 2023-12-31 | $140.19 Million | $-79.65 Million | -0.568x | -98.36% |
| 2022-12-31 | $194.45 Million | $-55.70 Million | -0.286x | +73.79% |
| 2021-12-31 | $99.03 Million | $-108.24 Million | -1.093x | -35.63% |
| 2020-12-31 | $205.49 Million | $-165.61 Million | -0.806x | -4.95% |
| 2019-12-31 | $193.19 Million | $-148.35 Million | -0.768x | +31.83% |
| 2018-12-31 | $165.78 Million | $-186.74 Million | -1.126x | -28.02% |
| 2017-12-31 | $182.88 Million | $-160.91 Million | -0.880x | -258.89% |
| 2016-12-31 | $267.90 Million | $-65.68 Million | -0.245x | -195.04% |
| 2015-12-31 | $384.24 Million | $-31.93 Million | -0.083x | +53.34% |
| 2014-12-31 | $182.22 Million | $-32.45 Million | -0.178x | +45.72% |
| 2013-12-31 | $74.09 Million | $-24.31 Million | -0.328x | -23.20% |
| 2012-12-31 | $66.84 Million | $-17.80 Million | -0.266x | +49.14% |
| 2011-12-31 | $19.79 Million | $-10.36 Million | -0.524x | -- |